OBESITY MEDS

Question 1

What is Liraglutide approved for?

Answer 1

BMI ≥27 kg/m2 with obesity-related comorbidity

Liraglutide is a medication used to manage obesity in individuals with certain health conditions.

Question 2

What are the most common adverse effects of Liraglutide?

Answer 2

• Nausea (30%-40%)
• Vomiting
• Abdominal pain
• Diarrhea/constipation

These gastrointestinal effects are significant and can impact patient adherence.

Question 3

What is the withdrawal rate for Liraglutide due to severe gastrointestinal effects?

Answer 3

~6%

This withdrawal rate highlights the impact of side effects on treatment continuation.

Question 4

What is the risk of gallbladder disease associated with Liraglutide?

Answer 4

~5% incidence

Patients with a history of gallbladder disease should be monitored when using Liraglutide.

Question 5

Is Liraglutide safe post-cholecystectomy?

Answer 5

Yes

Patients who have had their gallbladder removed can safely use Liraglutide.

Question 6

For what conditions is Topiramate FDA approved?

Answer 6

• Epilepsy
• Migraines

Although it is not FDA approved for weight loss, some studies indicate its effectiveness in that area.

Question 7

What percentage of weight loss does Topiramate provide evidence for?

Answer 7

Sustained 6%-8% weight loss

This weight loss is significant, although Topiramate is not officially approved for this use.

Question 8

Why is Topiramate contraindicated in some patients?

Answer 8

Due to the risk of kidney stones

Patients with a history of kidney stones should avoid Topiramate due to the potential for stone formation.

Question 9

What is the contraindication for Phentermine/topiramate?

Answer 9

Patient’s history of kidney stones

This combination medication should be avoided in patients with this history.

Question 10

In what patients is Naltrexone/bupropion contraindicated?

Answer 10

Patients with uncontrolled hypertension

This contraindication is crucial for patient safety, as the medication can affect blood pressure.

Question 11

What is Liraglutide approved for?

Answer 11

BMI ≥27 kg/m2 with obesity-related comorbidity

Liraglutide is a medication used to manage obesity in individuals with certain health conditions.

Question 12

What are the most common adverse effects of Liraglutide?

Answer 12

• Nausea (30%-40%)
• Vomiting
• Abdominal pain
• Diarrhea/constipation

These gastrointestinal effects are significant and can impact patient adherence.

Question 13

What is the withdrawal rate for Liraglutide due to severe gastrointestinal effects?

Answer 13

~6%

This withdrawal rate highlights the impact of side effects on treatment continuation.

Question 14

What is the risk of gallbladder disease associated with Liraglutide?

Answer 14

~5% incidence

Patients with a history of gallbladder disease should be monitored when using Liraglutide.

Question 15

Is Liraglutide safe post-cholecystectomy?

Answer 15

Yes

Patients who have had their gallbladder removed can safely use Liraglutide.

Question 16

For what conditions is Topiramate FDA approved?

Answer 16

• Epilepsy
• Migraines

Although it is not FDA approved for weight loss, some studies indicate its effectiveness in that area.

Question 17

What percentage of weight loss does Topiramate provide evidence for?

Answer 17

Sustained 6%-8% weight loss

This weight loss is significant, although Topiramate is not officially approved for this use.

Question 18

Why is Topiramate contraindicated in some patients?

Answer 18

Due to the risk of kidney stones

Patients with a history of kidney stones should avoid Topiramate due to the potential for stone formation.

Question 19

What is the contraindication for Phentermine/topiramate?

Answer 19

Patient’s history of kidney stones

This combination medication should be avoided in patients with this history.

Question 20

In what patients is Naltrexone/bupropion contraindicated?

Answer 20

Patients with uncontrolled hypertension

This contraindication is crucial for patient safety, as the medication can affect blood pressure.